Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul F Lizzul

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Drugs in Dermatology : JDD|May 20, 2010
The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenationPaul F Lizzul, Vic A Narurkar
Journal of Drugs in Dermatology : JDD|March 5, 2015
A phase I safety and pharmacokinetic study of ATX-101: injectable, synthetic deoxycholic acid for submental contouringPatricia Walker, Jere Fellmann, Paul F Lizzul
Nature Reviews. Rheumatology|September 14, 2011
Management of psoriatic arthritis from the view of the dermatologistCaroline A Chang, Alice B Gottlieb, Paul F Lizzul
Journal of Drugs in Dermatology : JDD|May 9, 2013
Cutaneous clues to renal cell carcinoma: hereditary leiomyomatosis and renal cell carcinomaMelissa A Michelon, Christle J Layton, Chad J Jessup, et al.
The Journal of Investigative Dermatology|June 16, 2005
Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanerceptPaul F Lizzul, Abhishek Aphale, Rama Malaviya, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 28, 2016
Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental FatJeffrey S Dover, Jeffrey M Kenkel, Alastair Carruthers, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 28, 2016
Overview of ATX-101 (Deoxycholic Acid Injection): A Nonsurgical Approach for Reduction of Submental FatSteven H Dayan, Shannon Humphrey, Derek H Jones, et al.
Journal of the American Academy of Dermatology|July 20, 2016
ATX-101 for reduction of submental fat: A phase III randomized controlled trialShannon Humphrey, Jonathan Sykes, Jonathan Kantor, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 18, 2015
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat ReductionDerek H Jones, Jean Carruthers, John H Joseph, et al.
Aesthetic Surgery Journal|February 6, 2018
Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE TrialsSteven H Dayan, Joel Schlessinger, Kenneth Beer, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Drugs in Dermatology : JDD|May 20, 2010
The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenationPaul F Lizzul, Vic A Narurkar
Journal of Drugs in Dermatology : JDD|March 5, 2015
A phase I safety and pharmacokinetic study of ATX-101: injectable, synthetic deoxycholic acid for submental contouringPatricia Walker, Jere Fellmann, Paul F Lizzul
Nature Reviews. Rheumatology|September 14, 2011
Management of psoriatic arthritis from the view of the dermatologistCaroline A Chang, Alice B Gottlieb, Paul F Lizzul
Journal of Drugs in Dermatology : JDD|May 9, 2013
Cutaneous clues to renal cell carcinoma: hereditary leiomyomatosis and renal cell carcinomaMelissa A Michelon, Christle J Layton, Chad J Jessup, et al.
The Journal of Investigative Dermatology|June 16, 2005
Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanerceptPaul F Lizzul, Abhishek Aphale, Rama Malaviya, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 28, 2016
Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental FatJeffrey S Dover, Jeffrey M Kenkel, Alastair Carruthers, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 28, 2016
Overview of ATX-101 (Deoxycholic Acid Injection): A Nonsurgical Approach for Reduction of Submental FatSteven H Dayan, Shannon Humphrey, Derek H Jones, et al.
Journal of the American Academy of Dermatology|July 20, 2016
ATX-101 for reduction of submental fat: A phase III randomized controlled trialShannon Humphrey, Jonathan Sykes, Jonathan Kantor, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 18, 2015
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat ReductionDerek H Jones, Jean Carruthers, John H Joseph, et al.
Aesthetic Surgery Journal|February 6, 2018
Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE TrialsSteven H Dayan, Joel Schlessinger, Kenneth Beer, et al.
Pageof 2